Please login to the form below

Not currently logged in
Email:
Password:

New head for Novo Nordisk in North America

US diabetes care specialist Novo Nordisk Inc has a new president

Jesper HøilandNovo Nordisk has appointed Jesper Høiland president of its US affiliate to replace Jerzy Gruhn, who has taken over the leadership of the European business from the recently retired Martin Soeters. 

Høiland assumed responsibility for the US operation earlier this month, moving from Zurich, Switzerland to Plainsboro, New Jersey.

In his new role he will be responsible for a region that accounted for 46 per cent of the company's reported sales in the first six months of this year and will report to executive vice president and chief operating officer Kåre Schultz. 

Having joined Novo Nordisk in 1987 as assistant area manager in Denmark, Høiland has worked for Novo Nordisk in a number of roles and regions, most recently as senior vice president of international operations. 

In this role he doubled employee numbers, tripled overall pharmaceutical sales and oversaw the spinoff of Novo's China operations as a separate regional entity. 

Høiland described his new move as “a great opportunity to lead an organisation that is both driving the growth of our business and helping solve one of the most pressing health challenges facing the United States, diabetes”.

29th August 2013

From: Research, Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

The concordance conundrum: understanding the complexities of behaviour change
Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved....
The concordance conundrum: creating space for open dialogue
Growing numbers of patients want a partnership model with their HCP, whereby both parties are equally involved in the decision-making process. This model has been linked with an increase in...
Switzerland
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...

Infographics